Skip to main content
TER logo

TER · Teradyne, Inc

Track TER — free
$400.64 -2.38 (-0.59%)
Market Cap
$62.28B
Shares
156.34M
Volume · Sep 30 1.53M Avg daily vol (3M) 3.12M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$403.02 Open$410.85 Day$399.84–415.61 52W close$132.08–483.84 Avg vol 30d2.5M Short int8.1M · 5.2% float · 3.2d Short vol60% Last earningsJul 29, 2026 DataJan 2020–Sep 2026 Filing10-Q · Jul 31

Up next

Next earnings call
Oct 28, 2026 Est · unconfirmed · in 4 wks
filed Jul 31, 2026
call held Apr 29, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$4.46B
Trailing 12 months
Net income (TTM)
$1.15B
Trailing 12 months
Revenue growth YoY
+103.9%
Year over year
Operating margin
30.2%
Trailing 12 months
P / E (TTM)
55.4
Trailing earnings · reciprocal yield 1.8%
FCF yield
1.3%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-1.5%
Year over year · fewer shares
Price change (1Y)
+200.0%
Trailing year
Short interest
5.2%
Latest settlement · 3.2 days to cover
View all 115 metrics

AI Brief

Q2 FY26 earnings call · Jul 29, 2026
Q2 FY26

TL;DR. Teradyne reported a second consecutive quarter of record revenue of $1,329M (up 104% YoY) and non-GAAP EPS of $2.47 (up over 300% YoY), driven by AI demand across all three segments. The company tightened full-year guidance to 50%-52% of annual revenue in 1H with a stronger second half outlook, while Q3 guidance of $1.2B-$1.3B and $1.85-$2.15 non-GAAP EPS represents a sequential decline from the record Q2.

Bullish
  • + Record memory revenue with book-to-bill over 2 and 2026 memory TAM likely >40% larger than 2025
  • + Compute revenue grew nearly 600% YoY; completed second hyperscaler correlation and shipped first merchant GPU order
  • + Free cash flow of $378M in Q2; first half FCF of $579M up 150% YoY
  • + Tightened full-year revenue outlook: 1H weighted to 50%-52% of annual with stronger 2H
Bearish
  • − Q3 guidance implies sequential revenue decline at midpoint and EPS step-down from $2.47 to ~$2.00
  • − Gross margin guided down to 58%-59% in Q3 from 59.8% in Q2 on mix and new product launches
  • − Compute revenue expected to decline in 2H on order timing after being flat Q/Q in Q2
  • − Mobile revenue remains muted and below historical levels
  • − OPEX rising to 29%-30% of sales in Q3 from continued R&D and go-to-market investment
  • − Q3 non-GAAP operating margin guided to 28%-30%, below Q2's 33.7%

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 16 · calm Equity put/call 0.38
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +22%
above
Price vs 50-day avg +8%
above
RSI (14) 59
neutral
MACD trend Positive
52-week position 77%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +15%
trailing
6-month return +12%
trailing
YTD return +108%
this year
Relative strength −1%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $372 › 200d $332 — 50d above 200d
Institutional flow Accumulating
+16% holders QoQ · +338 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
5.18% of float · ▲ +15.3% MoM · 3.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
1,440 holders — near 3-yr high, broad support
Squeeze score 65
elevated · 0–100
Fundamentals
Excellent
Revenue growth +13%
Y/Y
Gross margin 58%
contracting
EPS growth +5%
Y/Y
Free cash flow $450.4M
Valuation P/E 54.7
in line
Buyback $617.1M
remaining
Balance sheet $31.7M
net debt
Quant / Vol
risk profile
Very High
Volatility 77%
annualized · 1-yr
Max drawdown −34%
past year
ATR 5.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 8 of last 8
Latest guidance · from the 8-K filed Jul 29, 2026
Revenue · third quarter of 2026 Initiated $1.2B – $1.3B
prior qtr $1.33B midpoint −5.9% QoQ
GAAP net income attributable to Teradyne per diluted share · third quarter of 2026 Initiated $1.79 – $2.09
prior qtr $2.38 midpoint −18.5% QoQ
Non-GAAP net income attributable to Teradyne per diluted share · third quarter of 2026 Initiated $1.85 – $2.15
Guided vs delivered · last 8 settled
Revenue third quarter of 2024
guided $680M – $740M
$737.3M In line
GAAP net income per diluted share third quarter of 2024
guided $0.62 – $0.82
$0.89 Beat +23.6%
Revenue second quarter of 2024
guided $665M – $725M
$729.88M Beat +5.0%
GAAP net income per diluted share second quarter of 2024
guided $0.90 – $1.10
$1.14 Beat +14.0%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
0 · 4 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+22% Bullish
Price vs 50-day avg
+8% Bullish
RSI (14)
59 Neutral
MACD trend
Positive Bullish
52-week position
77% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $372 › 200d $332 — 50d above 200d
Institutional flow Accumulating
+16% holders QoQ · +338 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
5.18% of float · ▲ +15.3% MoM · 3.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
1,440 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $132 Now $403 · 77% Range high $484
vs 200-day avg +22% vs 50-day avg +8%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Semiconductor Equipment & Materials — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
TER
Teradyne, Inc
this stock
$62.28B +108.2% +13.1% 54.7 5.2%
ASML
Asml Holding NV
$703.84B +71.5% — — 0.4%
LRCX
Lam Research Corp
$394.43B +89.2% +51.7% 54.7 2.1%
AMAT
Applied Materials Inc /De
$386.29B +99.2% -12.6% 42.0 1.8%
KLAC
Kla Corp
$245.53B — +11.7% 51.3 1.8%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
1,440
% held
102.7%
Net QoQ
+10.6M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
1,079
View
Short & Settlement
Short Interest Rising
Shares short
8.1M
Days to cover
3.2d
Change
+1.1M sh
View
Short Volume
Short vol %
60%
As of
Sep 30, 2026
Short Total
View
Fails to Deliver
FTD shares
2
Value
$767
As of
Sep 10, 2026
View
Off-Exchange
Off-exchange %
44.8%
Week of
Aug 24, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Buy
Member
Alan Armstrong
Amount
$1.0K–$15.0K
Traded
Mar 27, 2026
View
Financials
Financials
Revenue (FY)
$3.2B
Net income (FY)
$554.0M
EPS diluted
$3.47
View
Buybacks
Authorized
$2.0B
Remaining
$617.1M
Spent Remaining
View
Filings
SEC Filings
Latest
Investor Event Transcript
Filed
Sep 9, 2026
This year
10
View
Proposed Sales
Value
$140.4K
Shares
400
Filed
Sep 17, 2026
View
Earnings & Events
Earnings Calls
Last call
Sep 9, 2026
View

Performance

5D 20D 120D MTD YTD
TER +1.1% +15.2% +12.5% +15.2% +108.2%
SPY -1.2% -0.4% +13.1% -0.4% +12.1%
vs SPY +2.3% +15.6% -0.6% +15.6% +96.1%

Capital returns

Buyback program · as of Jun 28, 2026
Authorized
$2.00B
Spent (derived)
$1.38B
Remaining
$617.10M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 97210 CUSIP 880770102 13F (30d) 33 filings 22 filers Visit website Investor relations